Live from AIPIA: RFID Tags Could Save the U.K. National Health Service $500M/year

Diagnostic samples bound for one of the U.K.’s NHS pathology labs get a reusable storage system and low-cost RFID labels that save packaging, staff, and operational costs, among other benefits.

Alastair Hanlon, Chief Commercial Officer for PragmatIC
Alastair Hanlon, Chief Commercial Officer for PragmatIC

A new system implemented at one of the U.K.’s National Health Service pathology labs that implements RFID label technology has demonstrated a significant savings in staff, packaging materials, and operational costs. At the Active & Intelligent Packaging Summit Americas event in New Jersey, Alastair Hanlon, Chief Commercial Officer for PragmatIC, shared details on the project led by Quality Hospital Solutions (QHS), which employs PragmatIC’s flexible, low-cost RFID labels to track each patient sample from a doctor’s office to the NHS’s Gateshead, U.K., lab.

According to Hanlon, the facility processes up to 10,000 diagnostic samples per day—e.g., blood, urine, etc.—using state-of-the-art, fully automated technology. However, the approximately U.S. $25 million lab was working at significantly reduced capacity. The limiting factor? The movement of the samples before they arrived at the lab. Challenges occurred at the doctor’s-office level and in transit that resulted in inefficiencies at the laboratory.

With the traditional transport system, a sample was put into a bag, paperwork was added, and both were placed into another bag that was then joined with other samples in a third bag. Said Hanlon, the system used a tremendous amount of plastic and paper that could not be recycled, due to strict regulations in the healthcare industry. Thus, the materials were incinerated.

Another issue at the office level was that some samples were logged into IT systems but never sent, resulting in confusion at the lab as to whether they were phantom samples or had been lost.

During transit, samples were sometimes lost or damaged, or the barcode on the sample would become damaged and unreadable. Given that every time a patient visits a doctor in the U.K. there is an automatic U.S. $60 fee (approximately), Hanlon noted that requiring a patient to see the doctor a second time to provide another sample becomes costly—not to mention inconvenient for the patient.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?